CA-IX specific radiopharmaceuticals for the treatment and imaging of cancer

Details for Australian Patent Application No. 2009322171 (hide)

Owner Molecular Insight Pharmaceuticals, Inc.

Inventors Babich, John W.; Zimmerman, Craig; Joyal, John; Maresca, Kevin P.; Lu, Genliang; Hillier, Shawn

Agent FB Rice

Pub. Number AU-A-2009322171

PCT Pub. Number WO2010/065906

Priority 61/120,226 05.12.08 US; 61/180,341 21.05.09 US

Filing date 4 December 2009

Wipo publication date 10 June 2010

International Classifications

C07D 213/38 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 51/04 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61K 51/08 (2006.01) Preparations containing radioactive substances for use in therapy or testing

C07F 13/00 (2006.01) Compounds containing elements of the 7th Group of the Periodic System

Event Publications

30 June 2011 PCT application entered the National Phase

  PCT publication WO2010/065906 Priority application(s): WO2010/065906

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009322174-Automated substantiation of product level specific account payments

2009322170-Compounds having antiparasitic or antiinfectious activity